Researchers from the Indiana University Melvin and Bren Simon Comprehensive Cancer Center are part of an international team ...

Sidewinder Therapeutics, a biopharmaceutical company pioneering the development of next-generation bispecific ADCs (antibody-drug conjugates) for the treatment of cancer, today announced the closing ...

Gronvall reminded the audience there are currently two vaccines that do work to prevent cancer: the hepatitis B vaccine given ...

Analysts say the Tubulis platform technologies that yielded these ADCs could also help Gilead develop drugs in other ...

BostonGene, a leader in AI-powered solutions for drug discovery and development, is transforming how pharmaceutical companies develop, target, and deliver cancer therapies — making precision medicine ...

Researchers at The University of Texas MD Anderson Cancer Center have discovered a new blood-based biomarker that can help ...

A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...

Pediatric Cancer Research Foundation CEO Danielle Fragalla discusses the biological differences in pediatric cancer and the ...

We trained and tested ML systems that predict a deterioration in nine patient-reported symptoms within 30 days after treatments for aerodigestive cancers, using internal electronic health record (EHR) ...

The creation of a national cancer institute is a “significant institutional development” strengthening the oncological care in Cyprus, the Pancyprian Association of Cancer Patients and Friends ...

Severe respiratory viral infection increases risk for lung cancer, according to study results.The findings — derived from work in murine models and retrospective analyses of data from humans — ...